Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 292 | 362 | 154 | -69 | 126 |
| Gross Profit | 292 | 362 | 154 | -69 | 126 |
| Operating Expenses | 23,520 | 23,929 | 22,258 | 19,376 | 22,831 |
| Operating Income | -23,228 | -23,567 | -22,104 | -19,445 | -22,705 |
| Interest Expense | 1,065 | 1,045 | 1,003 | 687 | 1,010 |
| Other Income | 492 | 437 | 267 | -1,786 | 284 |
| Pre-tax Income | -23,801 | -24,175 | -22,840 | -21,918 | -23,431 |
| Net Income Continuous | -23,801 | -24,175 | -22,840 | -21,918 | -23,431 |
| Net Income | $-23,801 | $-24,175 | $-22,840 | $-21,918 | $-23,431 |
| EPS Basic Total Ops | -5.50 | -6.00 | -6.80 | -6.60 | -7.10 |
| EPS Basic Continuous Ops | -5.49 | -5.95 | -6.83 | -6.60 | -7.06 |
| EPS Diluted Total Ops | -5.50 | -6.00 | -6.80 | -6.60 | -7.10 |
| EPS Diluted Continuous Ops | -5.49 | -5.95 | -6.83 | -6.60 | -7.06 |
| EBITDA(a) | $-21,265 | $-21,569 | $-20,368 | $-18,147 | $-21,514 |